01 1Gemini PharmChem Mannheim GmbH
02 1Meiji Seika Pharma Co., Ltd.
03 1MicroBiopharm Japan Co., Ltd.
04 1Olon SpA
05 1Sicor S.r.l.
06 2Zhejiang Hisun Pharmaceutical Co., Ltd.
01 1Doxorubicin
02 6Doxorubicin Hydrochloride
01 2China
02 2Italy
03 2Japan
04 1U.S.A
NDC Package Code : 77391-001
Start Marketing Date : 2020-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12543-3209
Start Marketing Date : 2010-01-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10g/10g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 56161-101
Start Marketing Date : 1988-12-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (600g/600g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0260
Start Marketing Date : 2015-05-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53183-7000
Start Marketing Date : 2017-04-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58623-0029
Start Marketing Date : 1996-09-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58623-0119
Start Marketing Date : 2019-09-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
63
PharmaCompass offers a list of Doxorubicin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Doxorubicin Hydrochloride manufacturer or Doxorubicin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Doxorubicin Hydrochloride manufacturer or Doxorubicin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Doxorubicin Hydrochloride API Price utilized in the formulation of products. Doxorubicin Hydrochloride API Price is not always fixed or binding as the Doxorubicin Hydrochloride Price is obtained through a variety of data sources. The Doxorubicin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Duxocin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Duxocin, including repackagers and relabelers. The FDA regulates Duxocin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Duxocin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Duxocin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Duxocin supplier is an individual or a company that provides Duxocin active pharmaceutical ingredient (API) or Duxocin finished formulations upon request. The Duxocin suppliers may include Duxocin API manufacturers, exporters, distributors and traders.
click here to find a list of Duxocin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Duxocin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Duxocin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Duxocin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Duxocin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Duxocin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Duxocin suppliers with NDC on PharmaCompass.
We have 6 companies offering Duxocin
Get in contact with the supplier of your choice:
